Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension
SHEP Co-operative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991;265:3255-3261
Morbidity and mortality results from the European Working Party in High Blood Pressure in the Elderly trial
Amery A, Brixko P, Clement D et al. Morbidity and mortality results from the European Working Party in High Blood Pressure in the Elderly trial. Lancet 1985;i:1349-1354
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease
Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease. Lancet 1991;344:1383-1389
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
Sacks FM, Pfeffer MA, Moye LA et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001-1009
Effect of captopril on mortality and morbidity in patients with left ventricular disfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial
Pfeffer MA. Braunwald E, Moye LA et al. for the SAVE investigators. Effect of captopril on mortality and morbidity in patients with left ventricular disfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992;327.669-677
Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomised controlled trials
Atrial Fibrillation, Aspirin, Anticoagulation Study; Boston Area Anticoagulation Trial for Atrial Fibrillation Study; Canadian Atrial Fibrillation Anticoagualtion Study; Stroke Prevention in Atrial Fibrillation Study; Veterans Affairs Stroke Prevention in Non-rheumatic Atrial Fibrillation Study
Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomised controlled trials: Atrial Fibrillation, Aspirin, Anticoagulation Study; Boston Area Anticoagulation Trial for Atrial Fibrillation Study; Canadian Atrial Fibrillation Anticoagualtion Study; Stroke Prevention in Atrial Fibrillation Study; Veterans Affairs Stroke Prevention in Non-rheumatic Atrial Fibrillation Study. Arch Intern Med 1994;154:1449-1457